Myomo Inc. (MYO)
Myomo Inc. (MYO) Stock Price, Analysis & Data
| Bid | 1.45 |
| Market Cap | 57.83M |
| Revenue (ttm) | 43.26M |
| Net Income (ttm) | -14.51M |
| Beta | 1.44 |
| EPS (ttm) | -0.34 |
| PE Ratio (ttm) | n/a |
| Forward PE | -6.35 |
| P/B (ttm) | 6.27 |
| P/S (ttm) | 1.34 |
| Earnings Date | Nov 9, 2026 |
| Ask | 1.47 |
| Volume | 581,021 |
| Avg. Volume (20D) | 850,406 |
| Open | 1.48 |
| Previous Close | 1.52 |
| Day's Range | 1.46 - 1.55 |
| 52-Week Range | 0.60 - 1.59 |
| Analyst | Strong Buy |
| Price Target | 3 (105.48%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About MYO
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control te...
Financial Performance
In 2025, Myomo's revenue was 40.93M, an increase of 25.73% compared to the previous year's 32.55M. Earnings were -15.57M, an increase of 151.85%.
Financial StatementsAnalyst Forecast
According to 5 analyst ratings, the average rating for MYO stock is "Strong Buy". The 12-month stock price forecast is 3, which is upside of 105.48% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
